Clinical trial
The Effects of n-3 Polyunsaturated Fatty Acids on Renal and Cardiovascular Risk Markers in Renal Transplant Recipients: a Randomized Double Blinded Placebo Controlled Intervention Study.
NCT01744067 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effects of n-3 Polyunsaturated Fatty Acids on Renal and Cardiovascular Risk Markers in Renal Transplant Recipients: a Randomized Double Blinded Placebo Controlled Intervention Study.
- Lead sponsor
- Oslo University Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- November 30, 2013
- Completion date
- December 31, 2015
- Enrollment
- 132 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
disorder related to renal transplantation